Position in KROS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,977,595
+$797,883 QoQ
Shares Held
184,822
+73.0% QoQ
Ownership
0.932%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 132 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KROS Over Time
Shares Held
Position Value (USD)
Derivatives in KROS
reported options exposure · as of Mar 31, 2025CallValue
$917,100
CallShares
90,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names. KROS ranks #211 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in KROS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,977,595 | 184,822 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,179,712 | 106,858 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,483,455 | 220,209 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $843,933 | 53,346 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $182,961 | 13,705 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $917,100 | 90,000 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $2,376,338 | 233,203 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,901,256 | 878,159 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $33,273,529 | 572,990 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $17,958,089 | 392,956 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $457,000 | 10,000 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $22,353,290 | 337,663 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $20,759,809 | 522,128 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,505,337 | 204,057 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,603,021 | 39,896 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,040,727 | 24,373 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,704,921 | 181,277 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $3,572,113 | 65,688 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,086,051 | 52,744 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,195,014 | 181,876 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,965,380 | 116,915 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,017,810 | 130,265 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,204,416 | 87,956 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $337,063 | 8,739 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||